[Featured Stock] JinMatrix Hits Record High on News of European Certification for COVID-19 Diagnostic Kit
[Asia Economy Reporter Eunmo Koo] Jin Matrix is showing strong performance, recording a new high for two consecutive days. The news of the novel coronavirus (COVID-19) diagnostic kit 'Neoplex COVID-19' obtaining European in vitro diagnostic reagent (CE-IVD) certification appears to be influencing this trend.
As of 9:28 AM on the 11th, Jin Matrix was trading at 5,040 KRW, up 4.56% (220 KRW) from the previous trading day. During the session, the price rose to 5,820 KRW, marking a 52-week high.
Hot Picks Today
"It Has Finally Crossed Borders"... Greater Fear Due to Delayed Detection, No Treatment for Variant Ebola [Reading Science]
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
Jin Matrix announced the day before that its recently developed COVID-19 diagnostic kit, 'Neoplex COVID-19,' had obtained European CE-IVD certification. Neoplex COVID-19 ensures efficiency and simplicity for large-scale testing and significantly reduces the diagnostic time from the previous 6 hours to 3 hours.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.